ohitsbreadley

Totally consistent with white, christofascist, imperialist colonizer worldview.

To quote Bubba Gump:

Anyway, like I was sayin', [billionaire] is the fruit of the sea. You can barbecue it, boil it, broil it, bake it, saute it. There's uh, [billionaire]-kabobs, [billionaire] creole, [billionaire] gumbo. Pan fried, deep fried, stir-fried. There's pineapple [billionaire], lemon [billionaire], coconut [billionaire], pepper [billionaire], [billionaire] soup, [billionaire] stew, [billionaire] salad, [billionaire] and potatoes, [billionaire] burger, [billionaire] sandwich. That- that's about it.

Maybe I'm a smooth brain - but I always thought private trackers were kept private/exclusive as a way of promoting seeding - the exclusivity of private trackers lowers risk/fear of seeding, so people seed, files are kept alive. - the ratios are a stick to enforce the rules and boot leechers. Centralizing seed logs with private trackers always gave me the creeps though.

Honestly, it sounds like there's essentially no risk of seeding on I2P. Wouldn't more people be willing to seed in general? And wouldn't that in turn obviate the need for private trackers?

Alas, perhaps my smooth brain brings naivety along with it.

Because they are a corporation that is actively littering LEO with hundreds of satellites, and fear economic retribution and/or responsibility as a consequence of this kind of information?

You see how there might be something called "conflict of interest?"

Having a conflict of interest does not mean they aren't competent at what they do - just that they have reason to be biased against information that may result in direct consequence.

What makes you think it's anti-CRT?

...my mistake.

I think you meant "missed steak."

Hey - I might have given the wrong impression - I'm a civvy and never served. Grew up in a navy fam, so I have some exposure to life and lingo, but I won't pretend to know shit. Stolen valor is fucked up, so I'm sorry if I gave you that vibe. Thank you for your service sailor.

Oh okay. No disrespect, but from your other posts, I get the feeling you're fresh out of boot camp. A sense of pride is healthy, but it can get you in trouble if you don't keep it in check - loose lips sink ships.

Next time go with the euphemism for dropping a deuce, it's funnier.

How much is the fish?

Uh... not op... but, are you saying you're sitting at some console, browsing lemmy while waiting to get the go ahead to launch nukes?

It's always externalized exploitation because they're all multinational corporations.

It's true that many of the big players are based in the US, e.g. Pfizer, J&J, Merck, AbbVie, Abbott, EliLily, etc.

But there are plenty that aren't:

• Bayer, Boehringer Ingelheim, BioNTech, and Merck Group (MilliporeSigma in the US, distinct from Merck & Co) are headquartered in Germany.
• AstraZeneca and GlaxoSmithKline are in the UK.
• Roche and Novartis are in Switzerland.
• Novo Nordisk in Denmark.
• Sanofi in France.
• Takeda, Otsuka, and Astellas in Japan.

https://en.wikipedia.org/wiki/List_of_largest_biomedical_companies_by_revenue

It's important to note that much of the R&D pharma relies on is publicly funded via academic grants in research carried out at universities. It's not to say that pharma doesn't also carry out clinical research, which of course does carry a cost, but a lot of the development dollars for a given drug are spent well before they make it into pharma's hands.